EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploration of potential novel drug targets for rheumatoid arthritis by plasma proteome screening

Zhiqiang Ma, Ran Chen iD, Zibo Feng

PLOS Computational Biology · 2025

DOI: 10.1371/journal.pcbi.1013333 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Computational Biology, 2025. Verfasst von Zhiqiang Ma und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, The 2nd Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Proteome, Blood Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Circulating proteins play a critical role in rheumatoid arthritis (RA), yet few have been targeted therapeutically. This study aimed to identify novel protein targets for RA therapy.

Methods

We conducted a comprehensive proteome-wide Mendelian Randomization (MR), colocalization analysis, and summary-data-based MR (SMR) to explore potential causal relationships between plasma proteins and RA, with an overall sample size of 1,148,608. The GWAS data on plasma proteins were obtained from the FinnGen study, the UK Biobank Pharma Proteomics Project and Iceland GWAS data. Then, validation of key molecules’ differential expression pattern was done using external transcriptomic data from RA patients, while the Drug Signatures Database (DsigDB) was used to identify potential therapeutic drugs. Drugs and target proteins interactions was evaluated with molecular docking and molecular dynamics simulations approaches. Potential side effects of plasma proteins associated with RA were elucidated by phenome-wide association study (Phe-WAS) approach.

Results

Genetically predicted levels of 68 plasma proteins were associated with RA. After colocalization and SMR analysis, 6 plasma proteins (FCRL3, SUGP1, TNFAIP3, EHBP1, HAPLN4, and CILP2) have been passed all tests and identified as having potential as therapeutic targets for RA. Further Receiver operating characteristic curve (ROC) analysis indicated that three protiens (CILP2, TNFAIP3 and EHBP) have a good potential as biomarkers for RA. Differential gene analysis showed the downregulation of HAPLN4, FCRL3, EHBP1 and TNFAIP3 in RA, as well as the upregulation of CILP2 in RA. Further Phe-WAS suggested that targeting these proteins may have potential side effects.

Conclusion

Our study investigated the causal relationships between plasma proteins and RA, deepening our understanding of the molecular mechanisms and facilitating the development of new therapeutic drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidProteomeBlood ProteinsHumansGenome-Wide Association StudyMendelian Randomization AnalysisProteomicsComputational BiologyMolecular Docking SimulationAntirheumatic AgentsMolecular Dynamics Simulation

Substanzen

ProteomeBlood ProteinsAntirheumatic Agents

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, The 2nd Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
  • Department of Cardiology and Hypertension, Yanbian University Hospital, Yanji, Jilin, China.
  • The Laboratory of Metabolic Disorders and Vascular Aging, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Department of Wound Repair Surgery, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

ORCID-Profile: Ran Chen

Zitieren

APA

Ma, Z., Chen, R., & Feng, Z. (2025). Exploration of potential novel drug targets for rheumatoid arthritis by plasma proteome screening. PLOS Computational Biology. https://doi.org/10.1371/journal.pcbi.1013333

Vancouver

Ma Z, Chen R, Feng Z. Exploration of potential novel drug targets for rheumatoid arthritis by plasma proteome screening. PLOS Computational Biology. 2025. doi:10.1371/journal.pcbi.1013333

BibTeX
@article{Ma2025,
  author = {Ma, Zhiqiang and Chen, Ran and Feng, Zibo},
  title = {Exploration of potential novel drug targets for rheumatoid arthritis by plasma proteome screening},
  journal = {PLOS Computational Biology},
  year = {2025},
  doi = {10.1371/journal.pcbi.1013333}
}
Kostenlos starten →